The total value of the U.S. optical industry “increased modestly” from 2024 to 2025 despite fewer optical purchases and eye ...
Eye drops for presbyopia represent a major opportunity for patients, but their reception by eye care professionals since the ...
New AAV therapy for retinitis pigmentosa completes Phase I/II dosing, aiming to protect cones and slow vision loss; first readout targets 2027. SPVN06, a novel gene-agnostic adeno-associated virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results